Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Higher prolactin levels in women may be linked to pilonidal sinus disease.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Hirsutism severity is linked to androgen levels, especially in women with a lower LH/FSH ratio.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

Women can also experience hair loss due to hormone changes.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Hormonal treatments effectively manage acne in some women, especially with specific hormonal issues.

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

Endocrine disorders can cause various skin and hair issues.

Female hair loss is influenced by genetics and hormones, often starting in middle age or after hormonal changes.

Sex hormones affect brain injury differently in males and females.